Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Squamous Cell × Imatinib Mesylate × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Gastrointestinal Stromal Tumors 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia 3 Neoplasms 2 Neoplasm, Residual 2 Melanoma 2 Burkitt Lymphoma 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Cancer 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1 Philadelphia Chromosome 1 Myeloproliferative Disorders 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid 1 Leukemia, Biphenotypic, Acute 1 Hypereosinophilic Syndrome 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Graft vs Host Disease 1 Digestive System Neoplasms 1 Desmoid Tumors 1 Dermatofibrosarcoma 1 Congenital Bone Marrow Failure Syndromes 1 Chordoma 1

Interventions

pembrolizumab 5 Nivolumab 3 Cisplatin 3 Taxes 2 Paclitaxel 2 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 abemaciclib 1 Risk Factors 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Pemetrexed 1 Nimorazole 1 Injections 1 High-Intensity Focused Ultrasound Ablation 1 Erlotinib Hydrochloride 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Carboplatin 1 Biological Products 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡